MEDIPAL HOLDINGS CORPORATION has revised upward its consolidated net profit forecast for the fiscal year ending March 2027. The company cited the recording of gains on the sale of strategic shareholdings as extraordinary gains following a reduction in those holdings.
MEDIPAL HOLDINGS CORPORATION announced an upward revision to its full-year consolidated earnings forecast for the fiscal year ending March 2027.
The main reason cited for the revision was the recording of gains on the sale of strategic shareholdings as extraordinary gains following a reduction in those holdings.
The article provides no additional specific figures or timing details, and further disclosures are awaited.